Literature DB >> 3181342

Colony growth of normal and neoplastic cells in various concentrations of methylcellulose.

H C Kluin-Nelemans1, H W Hakvoort, J H Jansen, N Duinkerken, J F van den Burgh, J H Falkenburg, R Willemze.   

Abstract

To assess the semisolid character of methylcellulose (MC) and its ability to prevent cell migration and aggregation in clonogenic assays, we studied the influence of various concentrations of MC (0.7%-1.26%) on colony growth of neoplastic cell lines, normal bone marrow cells, and hairy cell leukemia (HCL). All cell lines (K562, HL-60, JOK-1, Daudi, and BB3, an IgM-kappa B-cell line) showed a prominent decrease in colony numbers and remarkable changes in colony morphology at rising MC concentrations, whereas no such influence could be demonstrated for HCL, mixed lineage colony-forming units (CFU-GEMM), granulocyte-macrophage CFU (CFU-GM), erythroid burst-forming units (BFU-E), and erythroid CFU (CFU-E). Despite a decrease in colony numbers at high MC concentrations, some cell lines showed a sustained proliferation as measured by growth index calculations and bromodeoxyuridine (BrdUrd) incorporation. This indicates that at certain MC concentrations colony formation is not always a reflection of proliferation. BrdUrd incorporation yielded an extremely low proliferation capacity for HCL. It is likely that HCL cells, which strongly aggregate, formed pseudo-colonies in spite of high MC concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181342

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  2 in total

1.  Inhibition of human macrophage colony formation by interleukin 4.

Authors:  J H Jansen; G J Wientjens; W E Fibbe; R Willemze; H C Kluin-Nelemans
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

Review 2.  The Rise of CRISPR/Cas for Genome Editing in Stem Cells.

Authors:  Bing Shui; Liz Hernandez Matias; Yi Guo; Ying Peng
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.